ADAI News

Smartphone App to Help Prevent Relapses

CaptureA new smartphone app developed in Seattle is aimed at the tens of thousands of Americans who complete intensive drug and alcohol rehab programs. In the months following treatment, risk of relapse is high, and a treatment counselor or sponsor can't monitor clients around the clock. But an always-on smartphone can watch you, coach you, alert someone, and even give rewards.

Developed by WeConnect data scientists and treatment experts based on evidence-based approaches, the idea behind the recovery app is to create a supportive community and incentives for people in drug and alcohol recovery treatment as a way to prevent relapses. The app is marketed to recovery centers and drug courts, which then provide it to patients as part of treatment.  The app tracks how long someone has been in recovery, compiles an inventory of completed treatment activities and provides a way to quickly alert friends and family on a designated call list if the user is in need of help.

Dr. Dennis Donovan, professor emeritus at the UW and former ADAI director, said few of the many available addiction recovery apps have been independently tested for efficacy. However, he foresees situations where they may be very useful.

"Apps like this can provide an opportunity to develop social support networks," Donovan said in an interview with NW News Network. "Many people may find it difficult, or they don't choose to attend things like Alcoholics Anonymous, Narcotics Anonymous, Cocaine Anonymous and so on, but can benefit from a social system that can enhance and provide support for their recovery process."

Donovan recently stepped down after 25 years as director of the UW's Alcohol and Drug Abuse Institute. He said that smartphone apps won't be the end-all, cure-all, but may work well as a complement to other treatment.

Read more and listen to the interview at NW News Network.

February 07, 2019 in ADAI news | Permalink

| | Pin It! |

NW Prevention Workforce Needs Assessment Survey

NWPTTCThe new Northwest Prevention Technology Transfer Center (NWPTTC) wants your help to understand substance misuse prevention needs of states, tribes, communities, and organizations in Alaska, Idaho, Oregon, and Washington.

The results from this needs assessment survey will be used to develop training and technical assistance services and resources to advance the ability of the 10 prevention workforce to achieve a meaningful reduction in substance misuse and its harmful consequences.

Who should take the survey?

  • State and community substance misuse prevention coordinators
  • Primary, secondary and post-secondary educators
  • School counselors
  • Coalition members including: 
    • Public Health Professionals
    • Behavioral Health Aides
    • Faith-based Leaders
    • Parents
    • Medical Professionals
    • Non-profit Service Providers
    • Youth Advocates
    • Local and State Officials
    • Business Representatives
    • Mental Health Advocates and Treatment Providers
    • Substance Use Disorder Treatment Professionals
    • Other Community Partners

Please take the survey and share with colleagues: NW Prevention Workforce Needs Assessment Survey

January 29, 2019 in Washington state | Permalink

| | Pin It! |

21st Fundamentals of Addiction Medicine Conference, March 7-8, 2019 in Everett, WA

Addiction Medicine ConferenceThe largest of its kind in the Pacific Northwest, the annual Fundamentals of Addiction Medicine Conference provides the latest innovations and scientific developments in Addiction Medicine. Nationally and locally recognized experts will deliver the evidence- and case-based information that is necessary for providers to enhance their proficiency in diagnosis, treatment and management of patients with substance use disorders, even when complicated by overlapping or co-occurring disorders

This conference is designed for physicians, advanced practice nurses, physician assistants, medical directors, nursing, nursing leadership, administrators, counselors, social workers and those engaged with patients that have substance abuse disorders. CME is available for multiple professions.

21st Annual Fundamentals of Addiction Medicine Conference
March 7-9, 2019
Delta Marriott - Downtown Everett
[reservations]

Download brochure: http://bit.ly/2QTaOOL
Registration is open: http://bit.ly/2FgtHKd

January 16, 2019 in Events & training | Permalink

| | Pin It! |

Dr. Rick Ries Honored with Lifetime Achievement Award from WA State Health Care Authority

Richard-riesRichard Ries, MD, received a Lifetime Achievement Award from the Washington State Health Care Authority for his longstanding work with the annual Co-Occuring Disorders and Treatment Washington State Conference in October 2018.

Drs. Ries and Dennis Donovan (ADAI), started the COD & Treatment Conference in the late 1980s to share current information on co-occuring disorders and treatment among professionals from behavioral health, developmental disabilities, adult and youth corrections, and physical health. The goal of the conference is to promote integration of services across the public mental health, substance use disorder, developmental disabilities, and medical systems; promote knowledge about co-occurring disorders and the value of integration, to support the development of a co-occurring capable system of care, and to advocate and partner with others to promote integrated treatment and recovery for all people. Over 500 people were in attendance this year.

Congratulations, Dr. Ries!

January 15, 2019 in Washington state | Permalink

| | Pin It! |

Opportunity at ADAI through NIDA Summer Internship Program

NIDAsummeADAI’s Pacific NW Node of the NIDA Clinical Trials Network is participating in the NIDA Summer Internship Program in 2019.  Through this program, undergraduates age 18 and older are introduced to the field of drug abuse and addiction research by participating in research internships with NIDA's distinguished scientists at universities across the United States.  Students work with leading scientists for eight weeks during the summer (with pay!)  This is a great opportunity to work with and learn from scientists at the UW and at other universities across the U.S.! 

The intern(s) who come to ADAI in summer 2019 will work with our CTN Node research team, and have opportunities to see how addiction and related issues (opioid use, HIV, sexual risk, etc.) are treated and researched in real world settings.  (See more NIDA internships at UW and WSU).

Eligibility:  This program is designed to enhance the participation of underrepresented populations in science, however all racial/ethnic populations are eligible to apply.  Applicants must be at least 18 years old by May 31, 2019 and must be U.S. citizens or permanent residents of the United States (no exceptions). Graduating 2019 college seniors are also eligible to apply.   Deadline to apply: Monday, February 11, 2019 (11:59 PM EST).

  • Download the brochure
  • ADAI/CTN internship opportunity
  • Application form

Please let your students know about this excellent opportunity!

January 15, 2019 in ADAI news, Events & training, NIDA CTN | Permalink

| | Pin It! |

New Reports from ADAI Review Treatment & Policy Issues in Washington State

Three recent reports by the Alcohol & Drug Abuse Institute at the University of Washington address current issues of interest to treatment providers and policy makers in Washington State.  The reports were developed for the WA State Health Care Authority, Division of Behavioral Research (DBHR).

EBPreport_coverEvidence-based Practices in Washington State. Susan Stoner, UW Alcohol & Drug Abuse Institute, September 2018, 63p.  

In law and practice, Washington State has long promoted the use of evidence-based practices in the treatment of substance use disorders and mental health; Washington is recognized as a national leader in evidence-based policy-making.

This report reviews Washington's experience advancing evidence-based practices in mental health and substance use treatment. It presents a brief history of the evidence-based practices movement; touches on how the movement has affected policy-making; describes how policies have been translated into procedures in treatment for children and youth; contextualizes and characterizes where things stand with policies and procedures in the treatment of adults and substance use disorders; identifies key partners in the efforts to advance evidence-based practices in Washington; presents findings from a statewide survey about evidence-based practices; and offers some basic recommendations for the future of EBP.


YouthOUDmedsThe Role of Medications in the Treatment of Adolescents and Young Adults with OUD. Caleb Banta-Green and Laura Cooley.  UW Alcohol & Drug Abuse Institute, November 2018, 28p.

Diagnoses of opioid use disorder (OUD) among adolescents and young adults have increased substantially in the U.S. over the past 15 years. The use of treatment medications for opioid use disorder has also increased, though recent estimates show that only one in four young adults diagnosed with OUD have received any treatment medications.

The medications buprenorphine and methadone have strong evidence demonstrating their effectiveness; they are considered front-line treatment for opioid use disorder and are recommended by the American Academy of Pediatrics.  This report details the current evidence base for OUD treatment medications, along with expert guidance for prescribers and treatment providers on the use of these medications and supportive services.

MethinWA_coverMethamphetamine in Washington. Susan Stoner, Jason Williams, Alison Newman, Nancy Sutherland, and Caleb Banta-Green. UW Alcohol & Drug June 2018, 35p. Appendices A-E  

Methamphetamine use is a significant and increasing problem in Washington State. This report presents the scope of methamphetamine use; reviews harms associated with use; describes characteristics of users, their treatment utilization and needs; and reviews current approaches for treating methamphetamine use disorder. Finally, it notes key issues to consider when developing strategies aimed at reducing the use of and harms associated with methamphetamine use in Washington.  The report is informed by participants of a March 2018 meeting of the DBHR/ADAI Treatment Research Subcommittee, which focused on issues around methamphetamine use.


You can find more publications from ADAI on our website: http://adai.uw.edu/pubs/

 

January 15, 2019 in ADAI news, Publications, Washington state | Permalink

| | Pin It! |

ADAI Small Grants Awards for October 2018 Cycle

ResearchwordsADAI funded 3 Small Grants in the October 2018 cycle. The goal of the Small Grants Program is to stimulate research at the University of Washington by supporting promising pilot projects which may ultimately be developed into full studies with outside grant support.

Congratulations to the recipients!

  • PI: Vivian Lyons,  PhD Student in Epidemiology and ITHS Fellow; Ali Rowhani-Rahbar, MD, MPH, PhD, Associate Professor, Epidemiology (mentor): Prediction of Chronic Prescription Opioid and Benzodiazepine Use among Trauma Patients: A Statewide Longitudinal Study

  • PI: Benjamin Land, PhD, Research Assistant Professor, Pharmacology:  Do Edible Cannabinoids Prevent Morphine Tolerance in a Mouse Neuropathic Pain Model?

  • PI: Beatriz H. Carlini, PhD, MPH, Senior Research Scientist, Alcohol & Drug Abuse Institute:  Exploring the Potential of "Budtenders" as Harm Reduction Agents: A Study among Cannabis Retail Workers in Washington State

You can read abstracts of these projects here.

The next deadline for ADAI Small Grant applications is March 15, 2019.  Read more about ADAI's Small Grants Program and application process on the Small Grant web page.

December 14, 2018 in ADAI news | Permalink

| | Pin It! |

Position Open: Director, Alcohol and Drug Abuse Institute, University of Washington, Seattle

UW ADAI logo trans_highresThe University of Washington Alcohol and Drug Abuse Institute is seeking a new Director.  This is a great opportunity to lead a highly successful and impactful research institute.  ADAI is the home for the Pacific NW Node of the NIDA Clinical Trials Network and the Northwest Addiction Technology Transfer Center.

To apply: http://bit.ly/ADAI_director

ADAI Mission: To advance research, policy, and practice in order to improve the lives of individuals, families, and communities affected by alcohol and drug use and use disorder. https://adai.washington.edu/

ADAI Vision:  We believe that harms related to substance use are preventable and treatable, and that research plays a vital role in developing real-world solutions.  ADAI serves as a critical stimulus to develop new research and intervention strategies coupled with information dissemination and policy development to reduce harm to individuals, families, and communities.

The ADAI Director reports to the Executive Director, Health Science Administration (HSA), for administrative oversight.  Matters related to the scientific, health, information, and policy missions are managed and promoted by the Director with support from HSA.  The University of Washington provides an extraordinary environment for discovery, teaching, and service.  The University is recognized as one of the largest, most successful public universities in the world and a wide variety of partnerships are either existing or available to the Director to further the ADAI mission.

While ADAI is not an academic unit, opportunities exist for the Director to pursue joint academic appointment with an academic department depending on interest and alignment.

RESPONSIBILITIES:
• Provide scientific, policy, information dissemination and practice leadership of ADAI
• Has their own active portfolio of relevant research/evaluation/policy analysis and external grant support
• Facilitate and support ADAI  researchers to acquire and manage external grants and contracts
• Provide mentoring, support, and supervision for the further development of ADAI researchers
• Along with assigned staff, provide general oversight for the ADAI Small Grants Program
• Develop and maintain collaborative working relationships/partnerships with local, State, tribal, regional, and national organizations and agencies whose work is related to the mission of ADAI
• Facilitate and support involvement of graduate students and postdoctoral fellows in ADAI activities
• Responsible for oversight of ADAI administration, personnel and financial operations
• With administrative staff, Prepare and oversee ADAI’s annual and biennial operating budgets
• Oversee ADAI strategic planning efforts
• Attend quarterly Health Sciences Administration (HSA) Directors’ meetings and assure that ADAI and its operation are consistent with HSA policy and procedures
• Represent ADAI within University administrative committees and task forces as requested
• Serve as a reviewer of substance-related Washington State legislation that may affect the University’s operations or finances for the Office of Budget and Planning

REQUIREMENTS:
• Ph.D., M.D., DrPH (or comparable terminal degree) in a field relevant to substance use / addiction
• Strong record of research productivity and/or policy and practice impacts in relevant areas of substance use/ addictions research, as reflected by:
o Record of peer-reviewed publications and national professional presentations
o Record of successful external funding
o Plans to maintain an actively funded program of research, evaluation, policy analysis, or evidence based practice dissemination
• Extensive demonstrated experience working with diverse stakeholders to advance the scientific understanding of addiction in order to impact policy and practice.

Equivalent education/experience will substitute for all minimum qualifications except when there are legal requirements, such as a license/certification/registration.

DESIRED EXPERIENCE
• Demonstrated skills in program management, particularly in areas related to substance use/addictions research/policy/practice activities
• Experience in recruiting, mentoring, and developing junior research scientists
• Although ADAI is not an academic unit, experience in teaching, training, and mentoring graduate students and/or postdoctoral fellows
• Recognition in the field of substance use/addictions research/policy/practice as demonstrated by involvement in professional organizations, editorial board memberships, review or advisory panel memberships
• Evidence of collaboration with other researchers, institutions, or organizations involved in substance use/addictions research/policy/practice at a state, regional or national level

As a UW employee, you will enjoy generous benefits and work/life programs.  For detailed information on Benefits for this position, click here.

Application Process:
The application process for UW positions may include completion of a variety of online assessments to obtain additional information that will be used in the evaluation process.  These assessments may include Workforce Authorization, Cover Letter and/or others.  Any assessments that you need to complete will appear on your screen as soon as you select “Apply to this position”. Once you begin an assessment, it must be completed at that time; if you do not complete the assessment you will be prompted to do so the next time you access your “My Jobs” page. If you select to take it later, it will appear on your "My Jobs" page to take when you are ready. Please note that your application will not be reviewed, and you will not be considered for this position until all required assessments have been completed.

November 16, 2018 in ADAI news, Jobs | Permalink

| | Pin It! |

King County Behavioral Health Legislative Forum: Thursday, Nov. 8, 6:00-8:30pm

2017KClegislative-forum 

Why should you attend the 2018 King County Behavioral Health Legislative Forum?

  • Share what matters to you.
    The forum begins with a public reception and dedicated time for constituents to meet informally with state legislators, county council members, and legislative staff. It’s a chance to sit down directly with your legislator and share what matters most to you, your family, and your community when it comes to mental health and substance use. Click here to see the list of elected officials who plan to attend.
  • Learn what we’re working on this year.
    Every year, King County partners with elected officials to improve service systems and tackle challenges together. As part of the forum, King County will announce its legislative priorities in behavioral health -- what they'll be working on with state and federal elected officials, like improving access to community-based treatment or preserving the protections of the Affordable Care Act.
  • Help fight stigma about mental health and substance use.
    Sharing with your friends, family, and community how substance use and mental health impact your life or your loved ones puts a face to an issue that is too often stereotyped or misunderstood. These conversations can save lives. When we change how individuals, communities, and systems see and treat people with substance use or mental health conditions, we make it easier to find help and maintain hope that recovery is possible.
  • Sit down with your legislator and county council members.
    Almost 20 elected officials and their staff plan to attend, and they really want to hear from you.
  • Celebrate people in recovery.
    On November 8, it’s time to celebrate the thousands of people in our communities who are in recovery or on a journey toward it. What can you do to support people who use behavioral health services, and their allies?

When: Thursday, November 8, 6:00-8:30 p.m.
Where: Seattle Center Exhibition Hall – 301 Mercer St, Seattle
Register: on Eventbrite.

The UW Alcohol & Drug Abuse Institute is proud to be one of many organizations helping to co-sponsor this event! 

Help spread the word! Use hashtag #KC4Recovery and encourage people to come -- there's plenty of room even if you have not registered.

November 01, 2018 in Events & training, Washington state | Permalink

| | Pin It! |

Webinar: Buprenorphine for the Treatment of Opioid Use Diosders: An Overview

Presenter: P. Todd Korthuis, MD, MPH
Wednesday, November 7, 2018, 10:00-11:30am (Pacific)

image from adai.uw.eduJoin the Northwest Addiction Technology Transfer Center (NWATTC) and the CTN Western States Node for an informative webinar featuring Dr. Todd Korthuis of Oregon Health & Science University (OHSU). Dr. Korthuis will review the biological basis of medications for OUD, present recent data on the effects of buprenorphine on patient outcomes, and introduce tools for integrating buprenorphine treatment into your current setting.

This event is free.  Download flyer | Register here!  

October 25, 2018 in Events & training, Northwest ATTC | Permalink

| | Pin It! |

« Newer | Older »
My Photo

August 2019

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Categories

  • ADAI news (123)
  • ATOD Research @ UW (56)
  • Events & training (131)
  • Jobs (22)
  • Library - new books (48)
  • Library - new journals (284)
  • Liquor privatization (11)
  • Marijuana (34)
  • NIDA CTN (17)
  • Northwest ATTC (10)
  • Publications (8)
  • StopOverdose.org (57)
  • Washington state (110)
See More

Search

Links

  • ADAI Home
  • ADAI Library
  • CTN PNW Node blog
  • NW Confederation
  • StopOverdose.org
  • University of Washington

ATOD News

  • Join Together Online
  • Marin Institute Alcohol News
  • SAMHSA Behavioral Health

Archives

  • August 2019
  • July 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018

Subscribe to this site

  • What is this?
Blog powered by Typepad

Your email address:


Powered by FeedBlitz

Bookmark and Share